Oral Cancer Biomarkers: Is it a Meaningless Game?
Journal Title: Dentistry – Open Journal - Year 2016, Vol 3, Issue 1
Abstract
There are forever new biomarkers discovered every now and then, claiming for their clinical diagnostic and prognostic potentials. When is it going to end or would it ever ends at all? During the preomics era, it used to be only a handful of protein markers with well-studied in-depth mechanism of actions. Then came an explosive big data era: genomics, transcriptomics, proteomics, epigenomics, metabolomics, etc., generating huge amount of biomolecular data beyond researchers’ ability to handle let alone understand their significance in health and disease.1,2 It was akin to a child walking into a candy shop overwhelmed by the choices. Researchers are currently busy trying to make sense of these data and slowly attempting to translate them into clinical benefits.2 Just within the field of oral cancer, omics data are being generated from all sorts of host samples types, including saliva, buccal swaps, tissue biopsies, serum, plasma, lymphatic fluids, etc. Within each sample type, one has choices of investigating Deoxyribonucleic acid (DNA), Ribonucleic acid (RNA), protein, metabolites, small molecules, etc, originating from various cellular compartments such as nuclei, cytoplasm, membranes, mitochondria, microvesicles (exosomes),3 extracellular fluids (serum, plasma, lymphatic fluids, etc) and etc. Disease and healthy samples are being compared in the aim to identify key driver ‘cancer biomarkers’ with clinical potentials. As cancer is now perceived as a disease due to ‘molecular reprogramming’,4 hence, biomarker researchers are trying to identify global molecular events that induce normal cell to reprogram itself into cancer. Given the complexity and heterogeneity of cancers, predictably, huge numbers of molecular differences exist between normal and cancer samples, and can vary from individual to individual.
Authors and Affiliations
Muy-Teck Teh
Keywords
Related Articles
- EP ID EP552144
- DOI 10.17140/ DOJ-3-e005
- Views 117
- Downloads 0
Accelerating Orthodontic Treatment: A Continuous Challenge
Every clinician will always aim for providing effective treatment, this can be accomplished by delivering the planned treatment goals over the shortest time possible, with minimal biological side effects and high levels...
Polymorphic Genetic Markers in Patients with Chronic Periodontitis
Introduction: Chronic periodontitis (CP) is an inflammatory disease caused by the interaction among dental plaque, periodontal tissues, and host immune responses, which causes bone resorption. Interleukin-6 (IL-6) and ma...
Peri-Implantitis: A Review of the Disease and Report of a Case Treated with Allograft to Achieve Bone Regeneration
Dental implants offer excellent tooth replacement options however; peri-implantitis can limit their clinical success by causing failure. Peri-implantitis is an inflammatory process around dental implants resulting in bon...
Churro Jumper Arch: A Modified Approach to Improve Efficiency
In this clinical innovation the Churro jumper has been modified, by inserting it on an auxillary wire which is placed on the mandibular arch, instead of directly placing it on the main arch wire, to improve its efficienc...
Early Childhood Caries: A Preventable Disease
Early Childhood Caries (ECC) is a preventable chronic disease which affects infants and children worldwide. The early detection of ECC can reduce pain, life threatening conditions and helps in the growth and the overall...